Key facts
- This page summarizes Bernhard Hoffmann's Form 4 filing for Ocuphire Pharma, Inc. (IRD).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 12 Jan 2024, 16:17.
Bernhard Hoffmann - 10 Jan 2024 Form 4 Insider Report for Ocuphire Pharma, Inc. (IRD)
- Reporting relationship
- SVP of Corp. Dev.
- Issuer ticker
- IRD
- Reported as of
- 10 Jan 2024
- Net transaction value
- -$13,161
- SEC form
- 4
- Accepted by SEC
- 12 Jan 2024, 16:17:14 UTC
- Prior SEC filing
- 12 Jan 2023
- Next SEC filing
- 22 Jan 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Stephanie Swan, by Power of Attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Bernhard Hoffmann filed Form 4 for Ocuphire Pharma, Inc. (IRD) on 12 Jan 2024.
Change
- Previous filing in this sequence was filed on 12 Jan 2023.
- Current net transaction value: -$13,161.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OCUP
transaction
Common Stock
Tax liability
- Transaction value
- $13,161
- Shares
- -4,031
- Change %
- -2.7%
- Price
- $3.26
- Shares after
- 142,697
- Date
- 10 Jan 2024
- Ownership
- Direct
* marks a reported price that did not pass the local price check.